We are live on
!
Find out more
PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+14.95%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+442.91%
AUM
$42.9B
AUM Growth
+$5.08B
(+13%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
20.88%
Holding
1,056
New
125
Increased
334
Reduced
349
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$220M |
| 2 |
Booking.com
BKNG
|
+$145M |
| 3 |
Texas Instruments
TXN
|
+$118M |
| 4 |
Idexx Laboratories
IDXX
|
+$101M |
| 5 |
UnitedHealth
UNH
|
+$99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$234M |
| 2 |
Kimberly-Clark
KMB
|
+$155M |
| 3 |
Becton Dickinson
BDX
|
+$151M |
| 4 |
Danaher
DHR
|
+$138M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$130M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 14.65% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Axalta
AXTA
$8.17B
| $1.57M | ﹤0.01% |
62,428
-54,766
| -47% | -$1.41M |
|
677
OceanFirst Financial
OCFC
$1.91B
| $1.56M | ﹤0.01% |
64,700
+24,200
| +60% | +$588K |
|
|
MNTX
678
DELISTED
Manitex International, Inc.
MNTX
| $1.54M | ﹤0.01% |
201,974
-44,400
| -18% | -$324K |
|
679
Philip Morris
PM
$295B
| $1.53M | ﹤0.01% |
17,350
-41,651
| -71% | -$3.35M |
|
680
Amdocs
DOX
$6.22B
| $1.52M | ﹤0.01% |
28,096
+7,743
| +38% | +$435K |
|
681
Atara Biotherapeutics
ATRA
$76.1M
| $1.5M | ﹤0.01% |
1,512
-9,169
| -86% | -$8.52M |
|
682
Qiagen
QGEN
$8.72B
| $1.5M | ﹤0.01% |
34,820
+4,431
| +15% | +$178K |
|
683
American Eagle Outfitters
AEO
$3.01B
| $1.5M | ﹤0.01% |
67,600
+26,900
| +66% | +$553K |
|
684
Wabtec
WAB
$49.3B
| $1.49M | ﹤0.01% |
+20,267
| New | +$1.46M |
|
685
RLJ Lodging Trust
RLJ
$1.69B
| $1.48M | ﹤0.01% |
84,335
-74,100
| -47% | -$1.35M |
|
|
ICPT
686
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.47M | ﹤0.01% |
+13,130
| New | +$1.43M |
|
687
Newmark Group
NMRK
$2.63B
| $1.44M | ﹤0.01% |
173,100
+94,000
| +119% | +$892K |
|
|
SEM
688
DELISTED
Select Medical
SEM
| $1.42M | ﹤0.01% |
187,499
+30,439
| +19% | +$245K |
|
689
Consolidated Edison
ED
$39.9B
| $1.39M | ﹤0.01% |
16,385
+13,492
| +466% | +$1.08M |
|
690
Ceco Environmental
CECO
$4.14B
| $1.38M | ﹤0.01% |
191,267
-12,560
| -6% | -$91.1K |
|
691
News Corp Class A
NWSA
$15.4B
| $1.37M | ﹤0.01% |
110,275
-26,714
| -20% | -$336K |
|
692
American Homes 4 Rent
AMH
$12.5B
| $1.37M | ﹤0.01% |
60,125
-248,966
| -81% | -$5.45M |
|
|
PFC
693
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.36M | ﹤0.01% |
+47,463
| New | +$1.37M |
|
694
Altria Group
MO
$114B
| $1.34M | ﹤0.01% |
23,358
-4,863
| -17% | -$249K |
|
695
Starwood Property Trust
STWD
$6.09B
| $1.3M | ﹤0.01% |
58,335
-14,403
| -20% | -$314K |
|
696
Kraft Heinz
KHC
$30B
| $1.29M | ﹤0.01% |
39,604
-1,499,334
| -97% | -$61.1M |
|
697
Fennec Pharmaceuticals
FENC
$402M
| $1.27M | ﹤0.01% |
262,033
| – | – |
|
698
Sterling Infrastructure
STRL
$16.7B
| $1.26M | ﹤0.01% |
100,417
+14,900
| +17% | +$198K |
|
699
AdvanSix
ASIX
$444M
| $1.24M | ﹤0.01% |
+43,500
| New | +$1.32M |
|
700
nVent Electric
NVT
$26.7B
| $1.24M | ﹤0.01% |
45,947
-36,900
| -45% | -$946K |
|
Similar funds
MGIM
BC
WMSA
SS
PMEF
CC
GW
GC
Putnam Investments's Q1 2019 Portfolio in Review
As of Q1 2019, Putnam Investments held 1,056 positions worth $42.9B, up 13% from $37.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Putnam Investments's Q1 2019 filing shows 125 new, 334 increased, 349 reduced and 185 closed positions. Its largest new stake was Idexx Laboratories: 487,926 shares worth $109M. The largest sale was Jazz Pharmaceuticals, an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Putnam Investments's largest Q1 2019 buy was Idexx Laboratories: 487,926 shares worth $109M.
- Putnam Investments added most to Procter & Gamble in Q1 2019, an estimated $220M increase.
- Putnam Investments's biggest Q1 2019 reduction was Jazz Pharmaceuticals, cutting an estimated $234M.
- Putnam Investments fully exited Kellanova in Q1 2019, selling an estimated $43.1M.
- Putnam Investments's ten largest holdings make up 21% of its $42.9B portfolio in Q1 2019.
- Putnam Investments opened 125 new positions and closed 185 in Q1 2019.
- Putnam Investments's portfolio value rose 13% quarter-over-quarter to $42.9B.
Based on Putnam Investments's 13F filing for Q1 2019, filed 15 May 2019.